Clinical Trials Directory

Trials / Unknown

UnknownNCT06033326

Validation of the French Version of the Lithium Knowledge Test (LKT)

Validation of the French Version of the Lithium Knowledge Test (LKT) for Patients Treated With Lithium in Psychiatric Unit Hospitals

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Lithium is a drug used to treat several psychiatric illnesses. This medication requires particular vigilance because it has a narrow therapeutic margin: the dose necessary to obtain an effective treatment is close to the toxic dose. The blood dosage of the drug and the patient's knowledge of the drug are necessary to optimize and secure the drug intake. The objective of this observational study is to confirm that the score obtained by the LKT lithium knowledge self-questionnaire translated into French is representative of the knowledge of patients treated with lithium. Participants will be asked to complete this questionnaire twice, and the scores obtained will be compared to the blood lithium level to see if a good score is associated with an effective blood lithium concentration.

Conditions

Timeline

Start date
2023-09-30
Primary completion
2025-10-10
Completion
2025-10-10
First posted
2023-09-13
Last updated
2023-09-13

Source: ClinicalTrials.gov record NCT06033326. Inclusion in this directory is not an endorsement.

Validation of the French Version of the Lithium Knowledge Test (LKT) (NCT06033326) · Clinical Trials Directory